Afobazole Protects Rats Exposed to Peat Smoke In Utero
| LEADER | caa a22 4500 | ||
|---|---|---|---|
| 001 | 605538565 | ||
| 003 | CHVBK | ||
| 005 | 20210128100902.0 | ||
| 007 | cr unu---uuuuu | ||
| 008 | 210128e20150301xx s 000 0 eng | ||
| 024 | 7 | 0 | |a 10.1007/s10517-015-2830-z |2 doi |
| 035 | |a (NATIONALLICENCE)springer-10.1007/s10517-015-2830-z | ||
| 245 | 0 | 0 | |a Afobazole Protects Rats Exposed to Peat Smoke In Utero |h [Elektronische Daten] |c [D. Gorbatova, S. Litvinova, A. Durnev, S. Seredenin] |
| 520 | 3 | |a Female outbred albino rats were daily subjected to forced inhalations of peat smoke (4 cores packed with a mixture of peat (70%) and wood pulp (30%); 0.46 g, pH at least 5.5, core burning time 6 min,; total exposure 44 min) per se and in combination with oral afobazole (anxiolytic) in doses of 1 and 10 mg/kg on days 1-20 of pregnancy. Some groups of females received oral afobazole (200 mg/kg) after delivery, due to which their newborn rats received the drug in doses of 1-10 mg/kg with maternal milk on days 1-20 of life. Exposure to peat smoke inhibited body weight gain in the progeny on days 5-60 of life. Afobazole treatment during the pre- and postnatal periods prevented this effect. Open field testing showed that exposure to peat smoke prolonged the motor activity in the progeny and impaired the loss of orientation and exploratory behavior during repeated testing. Oral afobazole (1 and 10 mg/kg) during the prenatal and/or postnatal period (with maternal milk) prevented the effects of peat smoke. | |
| 540 | |a Springer Science+Business Media New York, 2015 | ||
| 690 | 7 | |a peat smoke |2 nationallicence | |
| 690 | 7 | |a prenatal period |2 nationallicence | |
| 690 | 7 | |a behavior |2 nationallicence | |
| 690 | 7 | |a open-field test |2 nationallicence | |
| 690 | 7 | |a afobazole |2 nationallicence | |
| 700 | 1 | |a Gorbatova |D D. |u Laboratory of Drug Toxicology, V. V. Zakusov Research Institute of Pharmacology, Moscow, Russia |4 aut | |
| 700 | 1 | |a Litvinova |D S. |u Laboratory of Drug Toxicology, V. V. Zakusov Research Institute of Pharmacology, Moscow, Russia |4 aut | |
| 700 | 1 | |a Durnev |D A. |u Laboratory of Drug Toxicology, V. V. Zakusov Research Institute of Pharmacology, Moscow, Russia |4 aut | |
| 700 | 1 | |a Seredenin |D S. |u Laboratory of Drug Toxicology, V. V. Zakusov Research Institute of Pharmacology, Moscow, Russia |4 aut | |
| 773 | 0 | |t Bulletin of Experimental Biology and Medicine |d Springer US; http://www.springer-ny.com |g 158/5(2015-03-01), 664-669 |x 0007-4888 |q 158:5<664 |1 2015 |2 158 |o 10517 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s10517-015-2830-z |q text/html |z Onlinezugriff via DOI |
| 898 | |a BK010053 |b XK010053 |c XK010000 | ||
| 900 | 7 | |a Metadata rights reserved |b Springer special CC-BY-NC licence |2 nationallicence | |
| 908 | |D 1 |a research-article |2 jats | ||
| 949 | |B NATIONALLICENCE |F NATIONALLICENCE |b NL-springer | ||
| 950 | |B NATIONALLICENCE |P 856 |E 40 |u https://doi.org/10.1007/s10517-015-2830-z |q text/html |z Onlinezugriff via DOI | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Gorbatova |D D. |u Laboratory of Drug Toxicology, V. V. Zakusov Research Institute of Pharmacology, Moscow, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Litvinova |D S. |u Laboratory of Drug Toxicology, V. V. Zakusov Research Institute of Pharmacology, Moscow, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Durnev |D A. |u Laboratory of Drug Toxicology, V. V. Zakusov Research Institute of Pharmacology, Moscow, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Seredenin |D S. |u Laboratory of Drug Toxicology, V. V. Zakusov Research Institute of Pharmacology, Moscow, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 773 |E 0- |t Bulletin of Experimental Biology and Medicine |d Springer US; http://www.springer-ny.com |g 158/5(2015-03-01), 664-669 |x 0007-4888 |q 158:5<664 |1 2015 |2 158 |o 10517 | ||